RNS Results25 Jan 2021 07:39
A POSITIVE RNS AND RESULTS FROM THE CHIEF EXECUTIVE Dr. Mariola Soehngen.
"The Company made good progress in 2020 and we were able to deliver results in line with the indications outlined in our H1 2020 report. The improved cash position at the end of 2020 provides a good platform for the new year and the substantial order book value we are carrying forward puts our service business in a strong position for 2021. We expect that the traction we are seeing on key partnerships developed in 2020 will continue.
Finally I would like to stress that I joined the company in September 2020 convinced that there is excellent potential in our business and markets. Proteomics is increasingly being regarded an integral part of research and development projects, so we expect the demand to increase further. I am excited to be on board, very pleased with the capability of the business and our people and convinced we have a bright future. We have begun a re-evaluation of our strategy and will evaluate both organic and external opportunities. I look forward to interacting with our shareholders and all other stakeholders and am convinced of the opportunity to create value for all constituents.
Great news to have cash in the bank and receive such positive comments from the Chief. I look forward to the Chief Executive's next update.
A good start to the week. GLA